No Picture
News

EvoNexus Technology Incubator in Partnership with EMD Performance Materials is Accepting Applications to Admit New Startups

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EMDPerformanceMaterials?src=hash" target="_blank"gt;#EMDPerformanceMaterialslt;/agt;–EvoNexus Technology Incubator in Partnership with EMD Performance Materials is … […]

No Picture
Events

SDBC event – Road to Commercialization : Jun 13, 2019

Road to Commercialization 2019: Customer Discovery & Validation to the Term Sheet: Lessons Learned
Can certain value propositions kill your business? How well do you really know your target end-user market and stakeholders, their buy-in motivations and… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Events

SCALE San Diego Event: SAN DIEGO Smart Cities Hackathon and Development Challenge Kick Off : Apr 06, 2019

Details and registration https://www.eventbrite.com/e/keynote-speaker-announced-ignite-scale-san-diego-smart-cities-development-challenge-kick-off-april-tickets-57734215593

From Apr 06, 2019 12:00AM to Apr 07, 2019 12:00AM at Downtown Works, 550 W B S… […]

No Picture
Events

The SHExperience: A Journey to Your Best Self : May 04, 2019

The SHExperience will inspire and empower women from all walks of life to discover skills and strategies to live and lead more courageously, making an impact in our lives and communities. Sponsored by Center for Women’s Leadership at USD.

Details and … […]

No Picture
News

New role for a driver of metastatic cancers

LA JOLLA?Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, Salk Institute researchers have revealed a new role for the CDK12 protein. The findings were published in the print version of Genes &amp… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Rubius cites some preclinical progress; Xencor scores deal with Astellas; Eidos to restate quarterly filings

? Rubius Therapeutics $RUBY has posted some positive ? though preclinical ? study results on its red blood cell tech, saying they were able to track a desired immune response using their drugs.The therapies are designed to increase the flow of T cells … […]

No Picture
News

Progenity Launches First Commercially Available, Custom-Designed, Noninvasive Prenatal Test for Monogenic Diseases

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company, announced today the launch of the Resura? Prenatal Test for Monogenic Disease, the first of its kind, commercially available, customizable, noninvasive prenatal test (… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Turning Point Therapeutics? Kinase Inhibitors Show High Potency against Targeted Oncogene Drivers and Their Mutations

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, presented data from four studies at AACR 2019, highlighting potent activity … […]